1.7796
price up icon2.00%   0.0296
 
loading
Schlusskurs vom Vortag:
$1.75
Offen:
$1.75
24-Stunden-Volumen:
87,240
Relative Volume:
0.14
Marktkapitalisierung:
$108.69M
Einnahmen:
$45.91M
Nettoeinkommen (Verlust:
$-4.62M
KGV:
-12.69
EPS:
-0.1402
Netto-Cashflow:
$-21.51M
1W Leistung:
+2.88%
1M Leistung:
+20.61%
6M Leistung:
-6.54%
1J Leistung:
+147.92%
1-Tages-Spanne:
Value
$1.665
$1.81
1-Wochen-Bereich:
Value
$1.665
$1.94
52-Wochen-Spanne:
Value
$0.27
$2.35

Equillium Inc Stock (EQ) Company Profile

Name
Firmenname
Equillium Inc
Name
Telefon
(858) 412-5302
Name
Adresse
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA
Name
Mitarbeiter
35
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-18
Name
Neueste SEC-Einreichungen
Name
EQ's Discussions on Twitter

Compare EQ vs VRTX, REGN, ARGX, ALNY, ONC

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
EQ
Equillium Inc
1.785 106.56M 45.91M -4.62M -21.51M -0.1402
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.31 121.40B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
765.92 83.25B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
724.67 46.39B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.39 43.41B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.71 33.09B 5.36B 287.73M 924.18M 2.5229

Equillium Inc Stock (EQ) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-28 Herabstufung Leerink Partners Outperform → Market Perform
2021-10-29 Fortgesetzt Stifel Buy
2021-09-15 Eingeleitet Cantor Fitzgerald Overweight
2020-07-14 Bestätigt H.C. Wainwright Buy
2020-07-10 Fortgesetzt Stifel Buy
2019-02-22 Eingeleitet SVB Leerink Outperform
Alle ansehen

Equillium Inc Aktie (EQ) Neueste Nachrichten

pulisher
Mar 02, 2026

EQ Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Volume Report: Can Equillium Inc withstand a market correctionJuly 2025 WrapUp & Real-Time Market Trend Scan - baoquankhu1.vn

Mar 02, 2026
pulisher
Mar 01, 2026

EQ Technical Analysis & ETF Price Forecast - Intellectia AI

Mar 01, 2026
pulisher
Mar 01, 2026

Short Interest in Equillium, Inc. (NASDAQ:EQ) Expands By 47.0% - MarketBeat

Mar 01, 2026
pulisher
Mar 01, 2026

Equillium (NASDAQ:EQ) Upgraded at Zacks Research - Defense World

Mar 01, 2026
pulisher
Feb 28, 2026

Equillium (NASDAQ:EQ) Stock Rating Upgraded by Zacks Research - MarketBeat

Feb 28, 2026
pulisher
Feb 28, 2026

Equillium (NASDAQ:EQ) Downgraded by Wall Street Zen to “Sell” - Defense World

Feb 28, 2026
pulisher
Feb 28, 2026

Equillium (NASDAQ:EQ) Downgraded by Wall Street Zen to "Sell" - MarketBeat

Feb 28, 2026
pulisher
Feb 28, 2026

EQ Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Feb 28, 2026
pulisher
Feb 25, 2026

Equillium: Multi-Cytokine Platform To Go Beyond Scope Of EQ504 For UC (NASDAQ:EQ) - Seeking Alpha

Feb 25, 2026
pulisher
Feb 25, 2026

Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference - The Manila Times

Feb 25, 2026
pulisher
Feb 25, 2026

Stifel Nicolaus Initiates Coverage on Equillium (NASDAQ:EQ) - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Biotech Equillium offers investor meetings at Leerink 2026 conference - Stock Titan

Feb 25, 2026
pulisher
Feb 24, 2026

Stifel initiates Equillium stock with buy rating on IBD potential - Investing.com Australia

Feb 24, 2026
pulisher
Feb 24, 2026

Aug Drivers: What is the next catalyst for IPGPMarket Trend Review & Real-Time Buy Signal Alerts - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 24, 2026

Stifel initiates Equillium stock with buy rating on IBD potential By Investing.com - Investing.com Canada

Feb 24, 2026
pulisher
Feb 23, 2026

Equillium (EQ) SVP Zedelmayer sells $328k in shares By Investing.com - Investing.com India

Feb 23, 2026
pulisher
Feb 23, 2026

Equillium (EQ) SVP Zedelmayer sells $328k in shares - Investing.com

Feb 23, 2026
pulisher
Feb 23, 2026

Equillium (NASDAQ:EQ) COO Sells $327,249.12 in Stock - MarketBeat

Feb 23, 2026
pulisher
Feb 23, 2026

Equillium (EQ) COO Zedelmayer sells 185,937 shares after exercising stock options - Stock Titan

Feb 23, 2026
pulisher
Feb 20, 2026

Fundamentals Check: Can Equillium Inc lead its sector in growth2025 Technical Patterns & Verified Momentum Stock Ideas - baoquankhu1.vn

Feb 20, 2026
pulisher
Feb 16, 2026

How sensitive is Equillium Inc. to inflationQuarterly Portfolio Report & Fast Gain Swing Alerts - mfd.ru

Feb 16, 2026
pulisher
Feb 15, 2026

Will Equillium Inc. stock gain from strong economyWeekly Earnings Recap & Stock Timing and Entry Methods - mfd.ru

Feb 15, 2026
pulisher
Feb 15, 2026

Equillium Conference: EQ504 Targets Ulcerative Colitis Ahead of Mid-Year Phase 1 Start - Defense World

Feb 15, 2026
pulisher
Feb 13, 2026

What’s next for Equillium Inc. stockJuly 2025 Opening Moves & High Accuracy Buy Signal Tips - mfd.ru

Feb 13, 2026
pulisher
Feb 09, 2026

Can Equillium Inc. stock deliver strong Q4 earningsJuly 2025 Sector Moves & Verified Chart Pattern Signals - mfd.ru

Feb 09, 2026
pulisher
Feb 04, 2026

Volume Recap: Is Equillium Inc forming a double bottom2025 Earnings Impact & Community Shared Stock Ideas - baoquankhu1.vn

Feb 04, 2026
pulisher
Feb 02, 2026

Equillium, Inc. (NASDAQ:EQ) Short Interest Up 32.2% in January - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

Equillium reports inducement grants under Nasdaq Listing Rule - marketscreener.com

Feb 02, 2026
pulisher
Feb 02, 2026

Equillium Reports Inducement Grants Under Nasdaq Listing Rule - TradingView

Feb 02, 2026
pulisher
Feb 02, 2026

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Feb 02, 2026
pulisher
Feb 01, 2026

Aug Gainers: Can AudioEye Inc be the next market leaderRecession Risk & AI Powered Market Trend Analysis - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 29, 2026

Celiac Disease Pipeline 2025: FDA Updates, Therapy Innovations, And Clinical Trial Landscape Analysis By Delveinsight AMYRA Biotech AG, Equillium Bio., Chugai Pharmaceutical, Calypso Biotech - Menafn.com

Jan 29, 2026
pulisher
Jan 17, 2026

Market Leaders: What is the target price for Equillium Inc stock2025 Trade Ideas & Expert Curated Trade Setups - baoquankhu1.vn

Jan 17, 2026
pulisher
Jan 14, 2026

Aug Technicals: Can Equillium Inc reach all time highs this yearBond Market & Weekly Consistent Profit Watchlists - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 13, 2026

Market Outlook: Is Equillium Inc stock a buy before product launchesIndex Update & Technical Pattern Recognition Alerts - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Does Equillium Inc stock have upside surprise potentialTrade Risk Report & Long-Term Safe Investment Ideas - baoquankhu1.vn

Jan 13, 2026
pulisher
Jan 13, 2026

Reviewing Mineralys Therapeutics (NASDAQ:MLYS) and Equillium (NASDAQ:EQ) - Defense World

Jan 13, 2026
pulisher
Jan 10, 2026

Will Equillium Inc. stock reach all time highs in 2025Market Trend Report & Accurate Buy Signal Notifications - Улправда

Jan 10, 2026
pulisher
Jan 09, 2026

Equillium principal accounting officer Tom Penny sells $8427 in stock - Investing.com India

Jan 09, 2026
pulisher
Jan 09, 2026

Equillium principal accounting officer Tom Penny sells $8427 in stock By Investing.com - Investing.com Australia

Jan 09, 2026
pulisher
Jan 08, 2026

Why Equillium Inc. stock is favored by top institutionsJuly 2025 Trends & Weekly Consistent Profit Watchlists - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Will Equillium Inc. stock benefit from sector rotationJuly 2025 Rallies & Low Volatility Stock Recommendations - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Is Equillium Inc. stock a top pick in earnings seasonWeekly Market Report & Fast Entry Momentum Alerts - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Can Equillium Inc. stock double in next 5 yearsEarnings Summary Report & Low Risk High Reward Trade Ideas - Улправда

Jan 08, 2026
pulisher
Dec 31, 2025

Equillium, Inc. (NASDAQ:EQ) Short Interest Up 22.7% in December - MarketBeat

Dec 31, 2025
pulisher
Dec 23, 2025

Equillium (NASDAQ:EQ) COO Christine Zedelmayer Sells 100,000 Shares - MarketBeat

Dec 23, 2025

Finanzdaten der Equillium Inc-Aktie (EQ)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Equillium Inc-Aktie (EQ) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Zedelmayer Christine
Sr. Vice President and COO
Feb 19 '26
Sale
1.76
185,937
328,104
191,444
$45.39
price down icon 4.35%
$52.62
price down icon 9.01%
$29.49
price down icon 0.10%
$103.05
price down icon 0.96%
$143.23
price down icon 4.45%
biotechnology ONC
$290.75
price down icon 2.83%
Kapitalisierung:     |  Volumen (24h):